Ratings by Morgan Stanley (David Lebowitz)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/4/2021 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Ionis Pharmaceuticals IONS Maintain Underweight
(N/A)
 
 
  Details
7/16/2021 Arcutis Biotherapeutics Inc. ARQT Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Avrobio Inc. AVRO Maintain Overweight
(N/A)
 
 
  Details
6/14/2021 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
5/28/2021 Ascendis Pharma ASND Maintain Overweight
(Overweight)
 
 
  Details
5/27/2021 Arcutis Biotherapeutics Inc. ARQT New Coverage Overweight
(N/A)
25.14
(20.80)
-17.26% Details
5/14/2021 Avrobio Inc. AVRO Maintain Overweight
(Overweight)
 
 
  Details
5/12/2021 Syndax Pharmaceuticals SNDX Maintain Equalweight
(Equalweight)
 
 
  Details
5/6/2021 Epizyme EPZM Maintain Equalweight
(N/A)
 
 
  Details
5/6/2021 Ionis Pharmaceuticals IONS Maintain Underweight
(Underweight)
 
 
  Details
4/30/2021 MacroGenics MGNX Maintain Underweight
(N/A)
 
 
  Details
4/30/2021 Blueprint Medicines BPMC Maintain Equalweight
(N/A)
 
 
  Details
4/30/2021 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
3/23/2021 Ionis Pharmaceuticals IONS Maintain Underweight
(Underweight)
 
 
  Details
3/12/2021 Zealand Pharma A/S ZEAL Maintain Overweight
(Overweight)
 
 
  Details
3/2/2021 Rhythm Pharmaceuticals RYTM Maintain Overweight
(Overweight)
 
 
  Details
2/26/2021 MacroGenics MGNX Maintain Underweight
(Underweight)
 
 
  Details
2/25/2021 Ionis Pharmaceuticals IONS Maintain Underweight
(Underweight)
 
 
  Details
2/25/2021 Epizyme EPZM Downgrade Equalweight
(Overweight)
10.41
(6.46)
-37.94% Details
2/19/2021 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(Equalweight)
 
 
  Details
2/18/2021 Rhythm Pharmaceuticals RYTM Maintain Overweight
(Overweight)
 
 
  Details
2/18/2021 Blueprint Medicines BPMC Maintain Equalweight
(Equalweight)
 
 
  Details
2/12/2021 Alnylam Pharmaceuticals ALNY Maintain Overweight
(Overweight)
 
 
  Details
2/4/2021 GW Pharma GWPH Downgrade Equalweight
(Overweight)
146.25
(218.96)
49.72% Details
12/7/2020 Nabriva Therapeutics AG NBRV Maintain Equalweight
(N/A)
 
 
  Details
12/7/2020 Syndax Pharmaceuticals SNDX Maintain Equalweight
(N/A)
 
 
  Details
11/30/2020 Rhythm Pharmaceuticals RYTM Maintain Overweight
(N/A)
 
 
  Details
11/25/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
11/3/2020 Rhythm Pharmaceuticals RYTM Maintain Overweight
(N/A)
 
 
  Details
11/3/2020 Karyopharm Therapeutics KPTI Maintain Overweight
(N/A)
 
 
  Details
10/30/2020 Blueprint Medicines BPMC Downgrade Equalweight
(Overweight)
104.63
(86.99)
-16.86% Details
9/4/2020 Akebia Therapeutics AKBA Maintain Equalweight
(N/A)
 
 
  Details
8/14/2020 Zealand Pharma A/S ZEAL Maintain Overweight
(N/A)
 
 
  Details
8/6/2020 Ionis Pharmaceuticals IONS Maintain Underweight
(N/A)
 
 
  Details
7/15/2020 Zealand Pharma A/S ZEAL Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Ionis Pharmaceuticals IONS Maintain Underweight
(N/A)
 
 
  Details
7/15/2020 Blueprint Medicines BPMC Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Avrobio Inc. AVRO Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Akebia Therapeutics AKBA Maintain Equalweight
(N/A)
 
 
  Details
7/2/2020 Karyopharm Therapeutics KPTI New Coverage Overweight
(N/A)
18.94
(7.82)
-58.71% Details
5/29/2020 Syndax Pharmaceuticals SNDX Maintain Equalweight
(N/A)
 
 
  Details
5/21/2020 Syndax Pharmaceuticals SNDX Maintain Equalweight
(N/A)
 
 
  Details
5/7/2020 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(N/A)
 
 
  Details
5/7/2020 Ionis Pharmaceuticals IONS Maintain Underweight
(N/A)
 
 
  Details
5/7/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
5/6/2020 Akebia Therapeutics AKBA Maintain Equalweight
(N/A)
 
 
  Details
4/30/2020 Blueprint Medicines BPMC Maintain Overweight
(N/A)
 
 
  Details
3/31/2020 Zealand Pharma A/S ZEAL Maintain Overweight
(N/A)
 
 
  Details
3/31/2020 Avrobio Inc. AVRO Maintain Overweight
(N/A)
 
 
  Details
3/17/2020 Nabriva Therapeutics AG NBRV New Coverage Equalweight
(N/A)
0.58
(1.21)
108.62% Details
3/11/2020 Syndax Pharmaceuticals SNDX Maintain Equalweight
(N/A)
 
 
  Details
3/11/2020 Rhythm Pharmaceuticals RYTM Maintain Overweight
(N/A)
 
 
  Details
2/26/2020 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
2/18/2020 Blueprint Medicines BPMC Maintain Overweight
(N/A)
 
 
  Details
2/12/2020 Avrobio Inc. AVRO Maintain Overweight
(N/A)
 
 
  Details
2/7/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
1/17/2020 Zealand Pharma A/S ZEAL Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Zealand Pharma A/S ZEAL Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Syndax Pharmaceuticals SNDX Maintain Equalweight
(N/A)
 
 
  Details
12/17/2019 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(N/A)
 
 
  Details
12/17/2019 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
12/6/2019 Epizyme EPZM Upgrade Overweight
(Equalweight)
15.81
(6.46)
-59.14% Details
11/21/2019 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
11/21/2019 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
11/21/2019 MacroGenics MGNX Downgrade Underweight
(Equalweight)
8.67
(24.78)
185.81% Details
11/11/2019 Rhythm Pharmaceuticals RYTM Maintain Overweight
(N/A)
 
 
  Details
11/7/2019 Ionis Pharmaceuticals IONS Downgrade Underweight
(Equalweight)
54.39
(37.81)
-30.48% Details
11/6/2019 Blueprint Medicines BPMC Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(N/A)
 
 
  Details
10/11/2019 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
10/11/2019 Blueprint Medicines BPMC Maintain Overweight
(N/A)
 
 
  Details
8/19/2019 Zealand Pharma A/S ZEAL Maintain Overweight
(N/A)
 
 
  Details
8/19/2019 Avrobio Inc. AVRO Maintain Overweight
(N/A)
 
 
  Details
8/8/2019 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
8/6/2019 Rhythm Pharmaceuticals RYTM Maintain Overweight
(N/A)
 
 
  Details
8/6/2019 Blueprint Medicines BPMC Maintain Overweight
(N/A)
 
 
  Details
8/6/2019 Rhythm Pharmaceuticals RYTM Maintain Overweight
(N/A)
 
 
  Details
5/13/2019 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
5/3/2019 Ironwood Pharmaceuticals IRWD Maintain Equalweight
(N/A)
 
 
  Details
5/2/2019 Nabriva Therapeutics AG NBRV Maintain Overweight
(N/A)
 
 
  Details
5/2/2019 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
4/3/2019 Blueprint Medicines BPMC New Coverage Overweight
(N/A)
81.03
(86.99)
7.36% Details
3/27/2019 Ironwood Pharmaceuticals IRWD Upgrade Equalweight
(Underweight)
13.75
(12.94)
-5.89% Details
3/8/2019 Syndax Pharmaceuticals SNDX Maintain Equalweight
(N/A)
 
 
  Details
3/5/2019 Alnylam Pharmaceuticals ALNY Upgrade Overweight
(Equalweight)
85.37
(183.44)
114.88% Details
3/1/2019 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
2/27/2019 Epizyme EPZM Maintain Equalweight
(N/A)
 
 
  Details
2/14/2019 Ironwood Pharmaceuticals IRWD Maintain Underweight
(N/A)
 
 
  Details
1/30/2019 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
11/7/2018 Ironwood Pharmaceuticals IRWD Maintain Underweight
(N/A)
 
 
  Details
11/7/2018 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
11/5/2018 Epizyme EPZM Maintain Equalweight
(N/A)
 
 
  Details
10/29/2018 Syndax Pharmaceuticals SNDX Downgrade Equalweight
(Overweight)
6.04
(13.87)
129.64% Details
10/24/2018 Clementia Pharmaceuticals Inc. CMTA Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
9/28/2018 Alnylam Pharmaceuticals ALNY Maintain Equalweight
(N/A)
 
 
  Details
9/28/2018 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
9/12/2018 Zealand Pharma A/S ZEAL New Coverage Overweight
(N/A)
17.21
(30.51)
77.28% Details
9/7/2018 Rhythm Pharmaceuticals RYTM New Coverage Overweight
(N/A)
31.50
(13.88)
-55.94% Details
9/7/2018 Nabriva Therapeutics AG NBRV New Coverage Overweight
(N/A)
2.62
(1.21)
-53.82% Details
9/7/2018 Akebia Therapeutics AKBA New Coverage Equalweight
(N/A)
8.16
(2.48)
-69.61% Details
9/7/2018 Epizyme EPZM New Coverage Equalweight
(N/A)
10.65
(15.81)
48.45% Details
9/7/2018 GW Pharma GWPH New Coverage Overweight
(N/A)
144.82
(218.96)
51.19% Details
8/28/2018 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
8/13/2018 Clementia Pharmaceuticals Inc. CMTA Maintain Overweight
(N/A)
 
 
  Details
8/13/2018 Avrobio Inc. AVRO Maintain Overweight
(N/A)
 
 
  Details
8/13/2018 Alnylam Pharmaceuticals ALNY Maintain Equalweight
(N/A)
 
 
  Details